Literature DB >> 31318414

Understanding the Signaling Pathways Related to the Mechanism and Treatment of Diabetic Peripheral Neuropathy.

He-Yong Tang1, Ai-Juan Jiang1, Jun-Long Ma1, Fan-Jing Wang1, Guo-Ming Shen1.   

Abstract

Worldwide, the most prevalent metabolic disorder is diabetes mellitus (DM), an important condition that has been widely studied. Diabetic peripheral neuropathy (DPN), a complication that can occur with DM, is associated with pain and can result in foot ulcers and even amputation. DPN treatments are limited and mainly focus on pain management. There is a clear need to develop treatments for DPN at all stages. To make this progress, it is necessary to understand the molecular signaling pathways related to DPN. For this review, we aimed to concentrate on the main signaling cascades that contribute to DPN. In addition, we provide information with regard to treatments that are being explored.
Copyright © 2019 Endocrine Society.

Entities:  

Year:  2019        PMID: 31318414     DOI: 10.1210/en.2019-00311

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Phytochemicals against anti-diabetic complications: targeting the advanced glycation end product signaling pathway.

Authors:  Amna Parveen; Razia Sultana; Seung Min Lee; Tae Hun Kim; Sun Yeou Kim
Journal:  Arch Pharm Res       Date:  2021-04-09       Impact factor: 4.946

2.  Study of the Involvement of the P2Y12 Receptor in Chronic Itching in Type 2 Diabetes Mellitus.

Authors:  Xiumei Xu; Huiqing Zhang; Lin Li; Runan Yang; Guilin Li; Shuangmei Liu; Günther Schmalzing; Hong Nie; Shangdong Liang
Journal:  Mol Neurobiol       Date:  2022-01-09       Impact factor: 5.590

3.  The Protective Effect and Mechanism of Dexmedetomidine on Diabetic Peripheral Neuropathy in Rats.

Authors:  Yan-Zhuo Zhang; Zhong-Cheng Zhou; Chun-Yu Song; Xia Chen
Journal:  Front Pharmacol       Date:  2020-07-30       Impact factor: 5.810

4.  The Axonal Glycolytic Pathway Contributes to Sensory Axon Extension and Growth Cone Dynamics.

Authors:  Andrea Ketschek; Rajiv Sainath; Sabrina Holland; Gianluca Gallo
Journal:  J Neurosci       Date:  2021-06-17       Impact factor: 6.167

Review 5.  Current Therapeutic Strategies in Diabetic Foot Ulcers.

Authors:  Aurelio Perez-Favila; Margarita L Martinez-Fierro; Jessica G Rodriguez-Lazalde; Miguel A Cid-Baez; Michelle de J Zamudio-Osuna; Ma Del Rosario Martinez-Blanco; Fabiana E Mollinedo-Montaño; Iram P Rodriguez-Sanchez; Rodrigo Castañeda-Miranda; Idalia Garza-Veloz
Journal:  Medicina (Kaunas)       Date:  2019-10-25       Impact factor: 2.430

6.  Clinical significance of apelin in the treatment of type 2 diabetic peripheral neuropathy.

Authors:  Hua Xu; Qi Wang; Qian Wang; Xuan Qiang Che; Xue Liu; Shumiao Zhao; Shitao Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

7.  Interventional Clinical Trials on Diabetic Peripheral Neuropathy: A Retrospective Analysis.

Authors:  Mengmeng Wang; Zepeng Zhang; Jia Mi; Guoqiang Wang; Lulu Tian; Yunyun Zhao; Xiaomin Li; Xiangyan Li; Xiuge Wang
Journal:  J Pain Res       Date:  2021-08-26       Impact factor: 3.133

8.  Dietary Omega-3 Polyunsaturated Fatty-Acid Supplementation Upregulates Protective Cellular Pathways in Patients with Type 2 Diabetes Exhibiting Improvement in Painful Diabetic Neuropathy.

Authors:  Alfonso M Durán; W Lawrence Beeson; Anthony Firek; Zaida Cordero-MacIntyre; Marino De León
Journal:  Nutrients       Date:  2022-02-11       Impact factor: 5.717

Review 9.  Novel Nanotechnological Approaches for Targeting Dorsal Root Ganglion (DRG) in Mitigating Diabetic Neuropathic Pain (DNP).

Authors:  Ranjana Bhandari; Ashmita Sharma; Anurag Kuhad
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-08       Impact factor: 5.555

10.  Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.

Authors:  Yixuan Lin; Chuqiao Shen; Fanjing Wang; Zhaohui Fang; Guoming Shen
Journal:  J Diabetes Res       Date:  2021-05-28       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.